SOD1 and amyotrophic lateral sclerosis: Although the primary efficacy endpoint as determined by the revised ALS functional rating scale was not met, secondary measures, including SOD1 CSF and plasma neurofilament light chain (a neuronal degeneration marker) levels, reached the goal of change from baseline.